MRNA - Company ID 0001682852
The table below shows Moderna, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.72B | $1.91B | $1.13B | $1.28B | $1.62B | $1.64B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $17.00M | $71.00M | $1.05B | $36.00M | $78.00M | $1.56B |
| Inventory | $280.00M | $146.00M | $332.00M | $240.00M | $128.00M | $412.00M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $5.82B |
| $5.77B |
| $6.60B |
| $6.17B |
| $6.77B |
| $9.67B |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $52.00M | $52.00M | $52.00M | $52.00M | $52.00M | $52.00M |
| Total assets | $10.96B | $11.49B | $12.13B | $12.01B | $12.70B | $15.80B |
| Accounts payable | $167.00M | $161.00M | $267.00M | $175.00M | $226.00M | $373.00M |
| Total current liabilities | $2.53B | $2.40B | $1.68B | $1.57B | $1.60B | $2.20B |
| Long-term debt | $591.00M | $590.00M | - | - | - | - |
| Total liabilities | $4.20B | $4.08B | $2.81B | $2.61B | $2.64B | $3.88B |
| Retained earnings | $5.10B | $5.88B | $8.05B | $8.25B | $9.07B | $11.16B |
| Total equity | $6.76B | $7.41B | $9.33B | $9.40B | $10.07B | $11.93B |